S100B protein: A useful marker in obstructive sleep apnea syndrome Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology Year: 2012
Relationship between obstructive sleep apnea syndrome (OSAS) and obesity, cholesterol disorders, blood pressure, and anatomical alterations Source: Eur Respir J 2006; 28: Suppl. 50, 817s Year: 2006
Metabolic disturbances in patients with obstructive sleep apnoea syndrome Source: Eur Respir Rev 2007; 16: 196-202 Year: 2007
Association between metabolic disturbances and inflammatory markers in obstructive sleep apnea (OSAS) patients Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008
Clock gene dysfunction in patients with obstructive sleep apnoea syndrome Source: Eur Respir J 2008; 32: 105-112 Year: 2008
Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation Source: Eur Respir J 2009; 33: 1195-1205 Year: 2009
Biochemical basis of inflammation in children with obstructive sleep apnea syndrome (OSAS) and in children with obesity Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism Year: 2011
Mortality in severe sleep apnoea/hypopnoea syndrome patients: impact of treatment Source: Eur Respir J 2002; 20: 1511-1518 Year: 2002
Obstructive sleep apnoea and metabolic impairment in severe obesity Source: Eur Respir J 2011; 38: 1089-1097 Year: 2011
Association of obstructive sleep apnea hypopnea syndrome with cardiovascular disease: a candidate gene association study Source: Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea Year: 2020
Nocturnal hypoxia as an additional factor of functional kidney damage in patients with obstructive sleep apnoea syndrome Source: Annual Congress 2008 - Weight control and comorbidity in obstructive sleep apnoea Year: 2008
Frequency of distribution of IL-1, IL-6 and TNFa gene polymorphism in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2006 - Metabolic control in obstructive sleep apnoea Year: 2006
Cystatin C and albuminuria as markers of kidney and cardiovascular diseases in obstructive sleep apnoea syndrome (OSAS) Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II Year: 2012
Leptin levels in children with obstructive sleep apnea syndrome Source: Annual Congress 2005 - Sleep apnoea in children Year: 2005
Association between lipid peroxidation and inflammation in obstructive sleep apnoea Source: Eur Respir J 2006; 28: 378-385 Year: 2006
Clinical, polysomnographic, antrophometric and inflammatory profile of patients with obstructive sleep apnea syndrome based on gender Source: Annual Congress 2008 - Assessment of sleep apnoea Year: 2008
Metabolic syndrome in obstructive sleep apnoea patients Source: Annual Congress 2007 - Sleep apnoea Year: 2007
Pathophysiology of central sleep apnea Source: Annual Congress 2005 - Central sleep apnoea Year: 2005
Circulating KL-6, a biomarker of lung injury, in obstructive sleep apnoea Source: Eur Respir J 2009; 33: 793-796 Year: 2009
BNP or VEGF levels do not predict disease severity in obstructive sleep apnoea syndrome (OSAS) Source: Eur Respir J 2005; 26: Suppl. 49, 40s Year: 2005